Fig. 1. The cumulative incidence of relapse forbcr-abl positive patients. / Ninety of 379 CML patients tested bcr-abl positive “late” after transplantation, and the cumulative incidence of relapse was 19% and 29% at 3 and 5 years, respectively, from the first positive assay.
Fig. 1.

The cumulative incidence of relapse forbcr-abl positive patients.

Ninety of 379 CML patients tested bcr-abl positive “late” after transplantation, and the cumulative incidence of relapse was 19% and 29% at 3 and 5 years, respectively, from the first positive assay.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal